pubmed-article:12109823 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12109823 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:12109823 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:12109823 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
pubmed-article:12109823 | lifeskim:mentions | umls-concept:C0205064 | lld:lifeskim |
pubmed-article:12109823 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
pubmed-article:12109823 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:12109823 | pubmed:dateCreated | 2002-7-11 | lld:pubmed |
pubmed-article:12109823 | pubmed:abstractText | To evaluate the role of concurrent cisplatin plus radiotherapy in the treatment of cervical cancer. | lld:pubmed |
pubmed-article:12109823 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12109823 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12109823 | pubmed:language | eng | lld:pubmed |
pubmed-article:12109823 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12109823 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12109823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12109823 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12109823 | pubmed:month | Jun | lld:pubmed |
pubmed-article:12109823 | pubmed:issn | 0936-6555 | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:ThomasGG | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:JohnstonMM | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:HirteHH | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:ElinRR | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:BrowmanGG | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:LukkaHH | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:FylesAA | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:TateUU | lld:pubmed |
pubmed-article:12109823 | pubmed:author | pubmed-author:FungM Fung... | lld:pubmed |
pubmed-article:12109823 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12109823 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:12109823 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12109823 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12109823 | pubmed:pagination | 203-12 | lld:pubmed |
pubmed-article:12109823 | pubmed:dateRevised | 2008-3-10 | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:meshHeading | pubmed-meshheading:12109823... | lld:pubmed |
pubmed-article:12109823 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12109823 | pubmed:articleTitle | Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. | lld:pubmed |
pubmed-article:12109823 | pubmed:affiliation | Hamilton Regional Cancer Centre, Ontario, Canada. himu.lukka@hrcc.on.ca | lld:pubmed |
pubmed-article:12109823 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12109823 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12109823 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12109823 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12109823 | lld:pubmed |